RWCS

Do you have a rheumatology question or case for Dr. Cush? Record it today and you might be featured in an upcoming podcast episode! buff.ly/p8Gp0hz

A Canadian cohort study on giant cell arteritis shows relapse in nearly half of patients, often after stopping treatment, and methotrexate didn’t significantly reduce that risk. Read more buff.ly/0eyLL09

The ALTO study, now published in Lancet Rheumatology, shows abatacept can delay progression to RA for up to 4 years in at-risk patients—marking a major step in RA prevention strategy. Read more buff.ly/LGBEXDC

At RNL26, Dr. Jeffrey Sparks delivered a state-of-the-art update on RA-ILD, highlighting recent advances in understanding and treatment, many driven by his own research group. Read more: buff.ly/EeJWSLb

At RheumNow Live, Pod IV tackled “Staying Ahead of Spondyloarthritis”—covering diagnosis, complications, and new advances in SpA care. Read more: buff.ly/5NG9Vr0

The American College of Physicians has released a new ethics position paper urging the end of the term "provider" for physicians, arguing it diminishes professionalism, clinical integrity, and ethical responsibility. Read more: buff.ly/0VZtJWg

Sunday’s vasculitis session at RNL26 featured updates on small and large vessel inflammation from Dr. Mike Putman and Dr. Clay Cockerell—covering diagnosis, pathology, and treatment pearls. Read more buff.ly/mRx8ssS

The FDA has asked Amgen to voluntarily withdraw avacopan (Tavneos) for ANCA-associated vasculitis. Amgen has declined, saying it will keep the drug on the market. buff.ly/zWGDhcR

Do you have a rheumatology question or case for Dr. Cush? Record it today and you might be featured in an upcoming podcast episode! buff.ly/p8Gp0hz

The TULIP-SC trial shows weekly subcutaneous anifrolumab delivers similar efficacy and safety to IV in patients with severe SLE. Read more: buff.ly/Ljonz9L

A real-world study of >500 children across 5 countries compared acitretin, cyclosporine, and methotrexate in pediatric psoriasis. MTX and acitretin showed better 2-year survival than cyclosporine. Dr. Jason Hawkes shares expert insight on what this means: buff.ly/c6hWQMe

In rheumatic disease patients with diffuse alveolar hemorrhage (DAH), a new study highlights high rates of coexisting pulmonary infection and elevated mortality risk. Read more: buff.ly/jJPtsjC

Lilly’s TOGETHER PsA trial shows combining ixekizumab with tirzepatide led to greater weight loss and improved PsA control vs. IXE alone. The results highlight a promising new approach for managing active PsA in patients with obesity. Read more: buff.ly/EMDQzig

A Norwegian registry study on RA pregnancies shows many patients stop antirheumatic meds during pregnancy, only to restart postpartum. Yet overall medication use increased during pregnancy. Important insights for treatment planning. Read more: buff.ly/nEFNBvv

New data in Arthritis & Rheumatology shows subcutaneous anifrolumab is as effective as IV for moderate-to-severe SLE, opening the door to more flexible, at-home treatment options for patients. Read more: buff.ly/SoMdehK

Do you have a rheumatology question or case for Dr. Cush? Record it today and you might be featured in an upcoming podcast episode! buff.ly/p8Gp0hz

New data links weight gain with increased low back pain risk—rising 7% for every BMI unit or 10 extra pounds. A reminder of the biomechanical burden obesity places on the spine. Read more: buff.ly/h1SMnH9

Reproductive health should be part of every SLE clinic visit. Rheumatology providers play a key role in educating patients, guiding pregnancy planning, and coordinating with gynecology for safer outcomes. Read more: buff.ly/FTzXzLI

Secure your spot at RWCS 2026 on Maui or online! 4 days of expert-led sessions, panels & pearls you can use now + next. Feb 11–14. In-person or virtual. Register now: buff.ly/gpU2tnF

A Swedish national study found patients with systemic sclerosis face a two-fold higher risk of hematologic malignancies, highlighting the need for increased vigilance in long-term care and screening. Read more: buff.ly/uMmnPvz